Study With Lu AF87908 in Healthy Subjects and Patients With Alzheimer's Disease
Status:
Recruiting
Trial end date:
2022-07-06
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the safety of a single dose of Lu AF87908, how
well it is tolerated and what the body does to the drug in healthy subjects and patients with
Alzheimer's Disease